# Phillips-Medisize wins contract to manufacture electronic drug delivery device

Phillips-Medisize, a Molex company, announced an agreement with a leading biotechnology company to manufacture a wearable, electronic-enabled combination drug delivery product, pending FDA approval, with launch slated for 2H 2020.

- Type: Contract
- Announced: 2019-10-22
- Where: Hudson, Wisconsin, United States
- Status: announced
- Products: wearable electronic-enabled combination drug delivery device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Phillips-Medisize Corporation](https://endata.com/companies/20563.md) (supplier)
- [Molex](https://endata.com/companies/20564.md) (partner)

## Sources

- [phillipsmedisize.com](https://phillipsmedisize.com/news/phillips-medisize-wins-contract-to-manufacture-first-electronic-enabled-combination-drug-delivery-product/), 2019-10-22: "This exciting new contract taps over 13 years of Phillips-Medisize's combination product expertise, which includes cold chain drug handling and first programs with API handling."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.